ID-LV305
ID-LV305-2013-001
Phase 1 mab completed
Quick answer
ID-LV305 for Melanoma - Currently Enrolling is a Phase 1 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Melanoma - Currently Enrolling
- Phase
- Phase 1
- Modality
- mab
- Status
- completed